- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT06269679
CBCT versus OPT over de mondgezondheidsstatus na 12 maanden van patiënten die in het ziekenhuis zijn opgenomen voor infectieuze endocarditis. (3D STARS)
3D-beeldvorming (Cone Beam Computed Tomography) versus orthopantomogram van de mondgezondheidsstatus na 12 maanden van patiënten die in het ziekenhuis zijn opgenomen voor infectieuze endocarditis: een multicenter gerandomiseerde superioriteitsgecontroleerde studie.
1. Infective Endocarditis (IE) is a rare and serious disease with high morbidity and mortality; 2. Streptoccoci of oral origin are the second more frequent microorganisms responsible for IE; 3. Oral Infectious Foci (OIF) are underdetected using the current recommended clinical examination/Orthopantomogram (OPT) approach; 4. Cone Beam Computed Tomography (CBCT) has a better sensitivity and sensibility to detect OIF than OPT; 5. To date, no study has been performed to assess the potential benefit of a clinical examination/CBCT approach on the oral health status in IE patients.
Thus, conducting a randomized controlled trial is highly desirable to assess the potential impact of a clinical examination/CBCT approach on the oral health status of patients hospitalized for IE and potentially to reduce IE new episodes.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
-
Bordeaux, Frankrijk
- Werving
- CHU Bordeaux - Site Pellegrin
-
Contact:
- Elise ARRIVE
- Telefoonnummer: +33/5 56 79 56 79
- E-mail: elise.arrive@u-bordeaux.fr
-
Clermont-Ferrand, Frankrijk
- Werving
- CHU Clermont-Ferrand
-
Contact:
- Magali VIDAL
- Telefoonnummer: +33473754405
- E-mail: mvidal@chu-clermontferrand.fr
-
Grenoble, Frankrijk
- Werving
- CHU Grenoble
-
Contact:
- Cécile CHATEL
- Telefoonnummer: +33/4 76 76 50 26
- E-mail: cchatel1@chu-grenoble.fr
-
Lyon, Frankrijk
- Werving
- HCL
-
Contact:
- Sarah MILLOT GUARD
- Telefoonnummer: +33426680250
- E-mail: sarah.millot-guard@chu-lyon.fr
-
Marseille, Frankrijk
- Werving
- APHM
-
Contact:
- Jean-Hugues CATHERINE
- Telefoonnummer: +33676320760
- E-mail: jean-hugues.catherine@ap-hm.fr
-
Nancy, Frankrijk
- Werving
- CHRU Nancy
-
Contact:
- Vanessa MOBY
- Telefoonnummer: +33/3 83 39 18 00
- E-mail: vanessa.moby@univ-lorraine.fr
-
Nantes, Frankrijk
- Werving
- CHU Nantes
-
Contact:
- Astrid GARREAU
- E-mail: astrid.garreau@chu-nantes.fr
-
Contact:
- Alexandra CLOITRE
- Telefoonnummer: +33/2.40.41.29.85
- E-mail: alexandra.cloitre@univ-nantes.fr
-
Paris, Frankrijk
- Werving
- AP-HP - Site Bretonneau
-
Contact:
- MESSECA Clément
- Telefoonnummer: +33/1 53 11 18 00
- E-mail: clement.messeca@aphp.fr
-
Toulouse, Frankrijk
- Werving
- CHU Toulouse
-
Contact:
- Sarah COUSTY
- Telefoonnummer: +33/5.61.32.20.30
- E-mail: cousty.s@chu-toulouse.fr
-
Tours, Frankrijk
- Werving
- CHRU Tours
-
Contact:
- Frédéric DENIS
- Telefoonnummer: +33/2 47 47 47 47
- E-mail: frederic.denis@univ-tours.fr
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Patients hospitalized or recently hospitalized for definite IE according to the 2015 ESC classification, naive patients for dental examination and imaging, whatever the IE responsible microorganism;
- Patients with a stable clinical state, meaning stabilized IE patients out of the critical phase, compatible with the performance of an OPT and a CBCT;
- Patients whose life expectancy is expected to be longer than 6 months;
- Patients who agree to visit the dental department of the hospital to carry out OIF eradication or at his/her personal dentist;
- Patients over 18 years old;
- Patients affiliated to a Social Security or a health insurance scheme;
- Patients who have given informed consent to participate to the study.
Exclusion Criteria:
- OPT or CBCT already performed before the inclusion of the patients in the study and available for the investigator during the patient's hospitalization.
- Medical contraindications to perform OPT or CBCT imaging;
- Absence of microbiologic identification of the IE responsible microorganism;
- Pregnant or breastfeeding women;
- Patients unable to give informed consent to participate to the study (under trusteeship, guardianship and legal protection).
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Diagnostisch
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Geen tussenkomst: OPT
Orthopantomogram = current recommended clinical examination approach (comparator procedure) |
|
|
Experimenteel: CBCT
Cone Beam Computed Tomography = experimental clinical examination approach (procedure under evaluation) |
Cone Beam Computed Tomography (CBCT) has a better sensitivity and sensibility to detect OIF. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Superiority of CBCT
Tijdsspanne: Month 12
|
Number of oral infectious foci detected using orthopantomogram versus Cone Beam Computer Tomography |
Month 12
|
|
Superiority of CBCT
Tijdsspanne: Month 12
|
DFMT index comprising the number of decayed, filled and missing teeth |
Month 12
|
|
Superiority of CBCT
Tijdsspanne: Month 12
|
Number of severe periodontitis sites |
Month 12
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Diagnostic at inclusion
Tijdsspanne: Day 0
|
Determine the diagnostic impact of clinical examination combined with CBCT at inclusion visit (Number of OIF detected at inclusion visit through clinical examination and CBCT versus clinical examination and OPT). |
Day 0
|
|
Incident symptomatic OIF
Tijdsspanne: Month 12
|
Monitor incident symptomatic OIF occuring during the study impacting the initial personalized OIF management (Number of incident symptomatic OIF detected during the study). |
Month 12
|
|
Incident asymptomatic OIF
Tijdsspanne: Month 12
|
Monitor incident asymptomatic OIF occuring during the study i.e. OIF absent at the initial examination but identified at the ultimate visit without symptomatic episode, in patients subjected to a clinical oral examination coupled with a CBCT (Number of incident asymptomatic OIF occuring during the study i.e. OIF absent at the initial examination but detected at the ultimate visit without symptomatic episode, in patients subjected to a clinical oral examination coupled with a CBCT). |
Month 12
|
|
Oral hygiene
Tijdsspanne: Day 0 and Month 12
|
Evaluate the oral hygiene of the IE patients included in the study (Oral hygiene using the Oral Hygiene Index- Simplified score (OHI-S) at inclusion visit and at the end-of-study visit). |
Day 0 and Month 12
|
|
Follow-up habits
Tijdsspanne: Day 0 and Month 12
|
Evaluate the follow-up habits of the IE patients included in the study by number of dental visits per year at inclusion visit and at the end-of-study visit). |
Day 0 and Month 12
|
|
Follow-up habits
Tijdsspanne: Day 0 and Month 12
|
Evaluate the follow-up habits of the IE patients included in the study by number of dental brushings per day (specific questionnaire already validated in French version) at inclusion visit and at the end-of-study visit). |
Day 0 and Month 12
|
|
Oral health quality of life
Tijdsspanne: Day 0 and Month 12
|
Assess the oral health quality of life of the IE patients included in this study (Oral health quality of life using by the short version of the self-administrated Oral Health impact profile-14 questionnaire (OHIP-14), at inclusion visit and at the end-of-study visit). |
Day 0 and Month 12
|
|
Premature end of study
Tijdsspanne: Month 12
|
Analyse the patient's premature end of study (Causes of the patient's premature end of study: loss to follow-up, death, patient withdrawing consent). |
Month 12
|
|
Impact of dental OIF
Tijdsspanne: Month 12
|
Number of dental OIF detected at the end-of-study visit through clinical examination versus number of periodontal OIF detected at the inclusion visit through clinical examination. |
Month 12
|
|
Impact of periodontal OIF
Tijdsspanne: Month 12
|
Number of periodontal OIF detected at the end-of-study visit through clinical examination versus number of periodontal OIF detected at the inclusion visit through clinical examination. |
Month 12
|
|
Impact of mucosal OIF
Tijdsspanne: Month 12
|
Number of mucosal OIF detected at the end-of-study visit through clinical examination versus number of periodontal OIF detected at the inclusion visit through clinical examination. |
Month 12
|
Medewerkers en onderzoekers
Sponsor
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- RC23_0336
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .